Perceive Pharma
Initial Transaction Details
Transaction Date
December 2024
Purpose of Financing
Venture
Stage of Company
Mid Stage
Structure of Financing
Equity
Perceive Pharma is advancing novel small molecule neuroprotective therapeutics, with lead pipeline programs in glaucoma and other ophthalmic diseases. Perceive was founded on compelling research that leveraged a comprehensive screening process in retina cells to identify maximally neuroprotective biological pathways.
Website